Beam Therapeutics Inc. (BEAM) – Analyst Ratings
-
Beam Therapeutics Inc (BEAM) PT Raised to $44 at JPMorgan
-
JPMorgan Upgrades Beam Therapeutics Inc (BEAM) to Overweight
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to BEAM Stock Lookup